Cypron
Brand names,
Cypron
Analogs
Cypron
Brand Names Mixture
Cypron
Chemical_Formula
C20H23NS
Cypron
RX_link
No information avaliable
Cypron
fda sheet
Cypron
msds (material safety sheet)
Cypron
Synthesis Reference
No information avaliable
Cypron
Molecular Weight
309.469 g/mol
Cypron
Melting Point
< 25 oC
Cypron
H2O Solubility
Soluble as HCl salt
Cypron
State
Liquid
Cypron
LogP
5.7
Cypron
Dosage Forms
Tablets (oral, 1 mg)
Cypron
Indication
Used for the symptomatic treatment of parkinsonism.
Cypron
Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Cypron
Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Cypron
side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Cypron
Patient Information
Cypron
Organisms Affected
Humans and other mammals